This article has been cited by
1Nephroprotective effect of saxagliptin against gentamicin-induced nephrotoxicity, emphasis on anti-oxidant, anti-inflammatory and anti-apoptic effects
Manar Gamal Helal,Marwa Mohamed Abdel Fattah Zaki,Eman Said
Life Sciences.2018;208()64
[DOI]
2Efficient New Protocols for Converting Primary Amides into Nitriles Initiated by P(NMe2)3, PCl3, or P(OPh)3
Imen Talbi,Mohamed Lotfi Efrit,Soufiane Touil
ACS Omega.2018;3(5)5078
[DOI]
3Sulfonamide-1,3,5-triazine–thiazoles: discovery of a novel class of antidiabetic agents via inhibition of DPP-4
Hai-De Gao,Peng Liu,Yang Yang,Fang Gao
RSC Advances.2016;6(86)83438
[DOI]
4Potential of pharmacological modulation of level and activity incretins on diabetes mellitus type 2
A.A. Spasov,N.I. Chepljaeva
Biomeditsinskaya Khimiya.2015;61(4)488
[DOI]
5Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus
Xiao-Wu Chen,Zhi-Xu He,Zhi-Wei Zhou,Tianxin Yang,Xueji Zhang,Yin-Xue Yang,Wei Duan,Shu-Feng Zhou
Clinical and Experimental Pharmacology and Physiology.2015;42(10)999
[DOI]
6Potential of pharmacological modulation of level and activity of incretins in diabetes mellitus type 2
A. A. Spasov,N. I. Chepljaeva
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry.2014;8(4)293
[DOI]
7Therapeutic experience of saxagliptin as first add-on after metformin in Indian type 2 diabetes patients: A non-interventional, prospective, observational study (ONTARGET-INDIA)
Sanjay Kalra,Sarita Bajaj,AG Unnikrishnan,ManashP Baruah,Rakesh Sahay,V Hardik,Amit Kumar
Indian Journal of Endocrinology and Metabolism.2019;23(3)312
[DOI]
8Pyrrolidine dithiocarbamate and saxagliptin ameliorate ulcerative colitis in rats
BerweenMahmoud Elmahmoudy,MaiA Abd El Fattah,MohamedF Elyamany,LailaA Rashed
Asian Pacific Journal of Tropical Biomedicine.2019;9(9)373
[DOI]
9Dynamic Compound-Dependent Acoustic Transfer to Investigate Inhibitor Reversibility
Jennifer Nothstein,Elisabeth MacColl,Paul Zuck,Jason Cassaday,Victor N. Uebele,Jeffrey D. Hermes,Michelle F. Homsher
SLAS TECHNOLOGY: Translating Life Sciences Innovation.2017;22(5)485
[DOI]
10Antisense Oligonucleotides As Potential Therapeutics for Type 2 Diabetes
Suxiang Chen,Nabayet Sbuh,Rakesh N. Veedu
Nucleic Acid Therapeutics.2020;22(5)485
[DOI]
11Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II–Induced Cardiac Diastolic Dysfunction in Male Mice
Scott M Brown,Cassandra E Smith,Alex I Meuth,Maloree Khan,Annayya R Aroor,Hannah M Cleeton,Gerald A Meininger,James R Sowers,Vincent G DeMarco,Bysani Chandrasekar,Ravi Nistala,Shawn B Bender
Endocrinology.2017;158(10)3592
[DOI]
12Novel univariate spectrophotometric determination of the recently released solid dosage form comprising dapagliflozin and saxagliptin via factorized response spectra: Assessment of the average content and dosage unit uniformity of tablets
Hayam M. Lotfy,Dalia Mohamed,Mona S. Elshahed
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2019;222(10)117120
[DOI]
13Electrochemical determination of Saxagliptin hydrochloride with MWCNTs/CuO/4'aminobenzo-18-crown-6-ether composite modified carbon paste electrode
Nehad A. Abdallah,Heba F. Ibrahim
Microchemical Journal.2019;147(10)487
[DOI]
14Efficacy and safety of add on therapy of bromocriptine with metformin in Indian patients with type 2 diabetes mellitus: A randomized open labeled phase IV clinical trial
Arijit Ghosh,Nilanjan Sengupta,Pranab Sahana,Debasis Giri,Parama Sengupta,Nina Das
Indian Journal of Pharmacology.2014;46(1)24
[DOI]
  Feedback 
  Subscribe